These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18220279)

  • 21. Nonalcoholic steatohepatitis.
    Walker JM
    Ann Intern Med; 1997 Sep; 127(5):411. PubMed ID: 9273839
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fatty liver hepatitis].
    Leiss O
    Dtsch Med Wochenschr; 1997 Jan; 122(5):140. PubMed ID: 9072485
    [No Abstract]   [Full Text] [Related]  

  • 23. "Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18.
    Yilmaz Y
    Hepatology; 2009 Sep; 50(3):990-1. PubMed ID: 19492431
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonalcoholic steatohepatitis.
    Moseley RH
    Ann Intern Med; 1997 Sep; 127(5):410-1. PubMed ID: 9273837
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis.
    Brunt EM
    Semin Diagn Pathol; 2005 Nov; 22(4):330-8. PubMed ID: 16939061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?
    Yilmaz Y; Dolar E
    World J Gastroenterol; 2009 Sep; 15(34):4346-7. PubMed ID: 19750583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
    Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
    J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe steatohepatitis in a patient with a rare neutral lipid storage disorder due to ABHD5 mutation.
    Ronchetti A; Prati D; Pezzotta MG; Tavian D; Colombo R; Callea F; Colli A
    J Hepatol; 2008 Sep; 49(3):474-7. PubMed ID: 18644654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis.
    Tanaka N; Horiuchi A; Yokoyama T; Kawa S; Kiyosawa K
    Am J Gastroenterol; 2008 Jan; 103(1):245-6. PubMed ID: 18184133
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonalcoholic steatohepatitis.
    Akpunonu BE; Federman DJ
    Ann Intern Med; 1997 Sep; 127(5):410; author reply 411. PubMed ID: 9273835
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic steatohepatitis].
    Petit P; Zarski JP
    Gastroenterol Clin Biol; 2000 Feb; 24(2):157-9. PubMed ID: 12687955
    [No Abstract]   [Full Text] [Related]  

  • 34. The epidemiology of nonalcoholic fatty liver disease: a global perspective.
    Lazo M; Clark JM
    Semin Liver Dis; 2008 Nov; 28(4):339-50. PubMed ID: 18956290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uncovered issues in the overview of nonalcoholic steatohepatitis.
    Wang CC; Kao JH
    J Formos Med Assoc; 2011 Dec; 110(12):798. PubMed ID: 22248838
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratin-18 as a marker of steatohepatitis.
    Gonzalez-Quintela A; Lojo S; Otero E; Perez LF
    Hepatology; 2007 Feb; 45(2):545. PubMed ID: 17256723
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
    Rubinstein E; Lavine JE; Schwimmer JB
    Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing nonalcoholic fatty liver disease from alcoholic liver disease: is ANI enough?
    Carvalho Filho RJ; Milani AN; Sampaio JP; Schiavon LL; Schiavon JN; Ferraz ML; Silva AE
    Gastroenterology; 2007 May; 132(5):2076-7; author reply 2077-8. PubMed ID: 17484908
    [No Abstract]   [Full Text] [Related]  

  • 40. A wider view on diagnostic criteria of nonalcoholic steatohepatitis.
    García-Monzón C; Fernández-Bermejo M
    Gastroenterology; 2002 Mar; 122(3):840-2. PubMed ID: 11878298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.